Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Spectral CT in Radiotherapy for Cervical Cancer
Where
Beijing
Age
18 years and over
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06433817
No phaseTaking people
a Single-arm, Single-center, Open Clinical Study
Where
Zhengzhou
Age
18 years to 75 years
People
10
Run by
Beijing Geekgene Technology Co., LTD
See details and how to joinNCT06431100
No phaseTaking people
Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery
Where
Guangzhou
Age
18 years and over
People
150
Run by
The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06420427
No phaseTaking people
Cervical Cancer Susceptible Population Classification
Where
Hefei
Age
18 years and over
People
10,000
Run by
Anhui Provincial Hospital
See details and how to joinNCT06405945
Phase 2Taking people
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Where
Changsha, Hangzhou, Jinan, Nanjing, Qingdao, Taiyuan
Age
18 years to 70 years
People
83
Run by
Shandong University
See details and how to joinNCT06251947
Phase 1/2Taking people
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
20
Run by
RenJi Hospital
See details and how to joinNCT06391190
No phaseTaking people
Toripalimab Combined With Definitive CCRT for LACC Patients
Where
Shanghai
Age
18 years and over
People
150
Run by
Ruijin Hospital
See details and how to joinNCT06256224
Phase 2Taking people
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Where
Wuhan
Age
18 years to 75 years
People
35
Run by
Zhongnan Hospital
See details and how to joinNCT05817214
No phaseTaking people
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Where
Mianyang, Yangchun
Age
9 years to 45 years
People
600
Run by
Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT05371353
Phase 2Not yet taking people in China
Myeloprotection With Trilaciclib in Pan-cancer Population
Where
Guangzhou
Age
18 years and over
People
132
Run by
Sun Yat-sen University
See details and how to joinNCT06297811
Phase 2Taking people
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer
Where
Beijing, Bengbu, Changsha, Chongqing, Hangzhou, Jinan, Kunming, Nanchang, Nanning, Shanghai, Shenyang, Tianjin
Age
18 years and over
People
116
Run by
RemeGen Co., Ltd.
See details and how to joinNCT06155396
Phase 1Taking people
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Where
Shanghai
Age
18 years to 75 years
People
32
Run by
HRYZ Biotech Co.
See details and how to joinNCT05952947
Phase 1Taking people
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Where
Wuhu
Age
18 years and over
People
36
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06215950
Phase 2Taking people
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Where
Shanghai
Age
18 years to 45 years
People
30
Run by
Xiaohua Wu
See details and how to joinNCT06209294
No phaseNot yet taking people in China
MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy
Where
Fuzhou
Age
20 years to 85 years
People
200
Run by
Fujian Cancer Hospital
See details and how to joinNCT06197126
Phase 3Taking people
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Where
Chengdu
Age
18 years and over
People
286
Run by
Sichuan Cancer Hospital and Research Institute
See details and how to joinNCT05173272
No phaseNot yet taking people in China
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
Where
Fuzhou
Age
13 years to 14 years
People
3,000
Run by
Fujian Maternity and Child Health Hospital
See details and how to joinNCT06137352
No phaseNot yet taking people in China
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Where
Fuzhou
Age
20 years to 85 years
People
500
Run by
Fujian Cancer Hospital
See details and how to joinNCT06101966
No phaseTaking people
The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.
Where
Chongqing
Age
18 years to 70 years
People
188
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT05749887
Phase 2Taking people
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Where
Xi'an
Age
18 years and over
People
20
Run by
Tang-Du Hospital
See details and how to joinNCT06055738
Phase 2Taking people
Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer
Where
Nanning
Age
18 years to 70 years
People
112
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT05511623
No phaseTaking people
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
Where
Chongqing
Age
18 years to 75 years
People
1,956
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT05378087
No phaseTaking people
Radiomics-based Malnutrition for Cervical Cancer.
Where
Hangzhou
Age
18 years to 80 years
People
150
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT05709769
No phaseTaking people
Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
Where
Guiyang
Age
18 years to 75 years
People
30
Run by
Guizhou Provincial People's Hospital
See details and how to joinNCT05950087
Phase 2Taking people
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Where
Suzhou
Age
18 years and over
People
32
Run by
Suzhou Municipal Hospital
See details and how to joinNCT05872724